accuRx Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 120
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $37.9M
Latest Deal Amount
  • Investors
  • 14

accuRx General Information

Description

Developer of a healthcare communication platform designed to communicate with patients. The company's platform aids to support nurses, administration staff practice managers, as well as general practitioners that include sending advice to patients, notifying a patient of normal results, and reminding them to book appointments and such communications are saved back to a patient's medical record to ensure a more joined-up approach, thereby enabling anyone involved in a patient's care to easily communicate with each other, and with the patient.

Contact Information

Website
www.accurx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Social/Platform Software
Communication Software
Primary Office
  • 27 Downham Road
  • London N1 5AA
  • England, United Kingdom
+44 020 0000 0000

accuRx Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

accuRx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series B) 15-Sep-2021 $37.9M 000.00 Completed Product Development
6. Early Stage VC (Series A) 21-Feb-2019 000.00 000.00 000.00 Completed Product Development
5. Grant 01-Mar-2018 00000 00000 Completed Startup
4. Seed Round 17-Mar-2017 00000 00000 00.000 Completed Startup
3. Grant 01-Mar-2017 00000 00000 Completed Startup
2. Accelerator/Incubator 06-Sep-2016 $114K $141K 00000 Completed Startup
1. Accelerator/Incubator 19-Jul-2016 $26.8K $26.8K 00000 Completed Startup
To view accuRx’s complete valuation and funding history, request access »

accuRx Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series B 0,000,000 00.000000 000.00 000.00 00 000.00 0.000
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
A Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
A Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 1,436,915 $0.000014 $0.23 $0.23 1x $0.23 8.41%
A Ordinary 800,000 $0.000014 $0.03 $0.03 1x $0.03 4.68%
To view accuRx’s complete cap table history, request access »

accuRx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a healthcare communication platform designed to communicate with patients. The company's platform aids to s
Other Healthcare Technology Systems
London, United Kingdom
120 As of 2021
000.00
00000000000 000.00

00000000

eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud ex
0000000000000 00000000
Victoria, Canada
000000000000

00000

henderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cup
00000 0000000000 0000000000 0000000
Amsterdam, Netherlands
00 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

accuRx Competitors (33)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TelmedIQ Private Equity-Backed Victoria, Canada 000000000000
00000 Venture Capital-Backed Amsterdam, Netherlands 00 000.00 00000000000 000.00
0000 Venture Capital-Backed Burlington, VT 00 00.000 000000000 00.000
0000000 Venture Capital-Backed Albuquerque, NM 00 000.00 000000&0 000.00
00000000 Venture Capital-Backed Denver, CO 00 0000 0000000000 0 0000
You’re viewing 5 of 33 competitors. Get the full list »

accuRx Executive Team (2)

Name Title Board Seat Contact Info
Jacob Haddad Co-Founder, Chief Executive Officer & Board Member
Laurence Bargery Co-Founder, Chief Technology Officer & Board Member
To view accuRx’s complete executive team members history, request access »

accuRx Board Members (4)

Name Representing Role Since
Irina Haivas MD Atomico Board Member 000 0000
Jacob Haddad accuRx Co-Founder, Chief Executive Officer & Board Member 000 0000
Laurence Bargery accuRx Co-Founder, Chief Technology Officer & Board Member 000 0000
Oliver Heimes Lakestar Board Member 000 0000
To view accuRx’s complete board members history, request access »

accuRx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

accuRx Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
British Patient Capital Fund of Funds Minority 000 0000 000000 0
Encore Capital PE/Buyout Minority 000 0000 000000 0
Lakestar Venture Capital Minority 000 0000 000000 0
Latitude VS Venture Capital Minority 000 0000 000000 0
Trusted Insight VC-Backed Company Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial